Top Biomarkers Companies

The market is primarily fuelled by the increasing incidence of chronic illness including cancer, cardiovascular disease, neurology, and diabetes, all of which are driving demand for diagnostics that are both timely and accurate. Advancement in genomics, proteomics, and high throughput screening have been instrumental in developing more definitive biomarker discovery and validation which is also a contributing factor to the market growth. The shift towards personalized medicine and companion diagnostics, which can leverage biomarker discovery, is another driver as patient-specific treatment plans lead to more favorable patient outcomes.

Industry Overview

According to SkyQuest Technology “Biomarkers Market By Product (Consumables, Services), By Type (Safety Biomarkers, Efficacy Biomarkers), By Research Area (Genomics, Proteomics), By Technology, By Disease Indication, By Application, By End User, By Region - Industry Forecast 2025-2032,” Global Biomarkers Market is projected to grow at a CAGR of over 12.3% by 2032, on account of urgent need for automating quantified data. The increase of investment into research and development by pharmaceutical and biotech companies, in concert with government support for funding and initiatives around precision medicine, is creating momentum in the growth of this market. The increase of clinical trial designs that utilize biomarkers to streamline drug development while simultaneously reduce costs represent a growing shift in the use of biomarkers to deliver scientifically sound approach to diagnostics and ultimately, improve patient efficacy

Top 10 Global Biomarkers Companies

1. Roche

Roche, established in 1896 and located in Basel, Switzerland, is among the top biotech and pharmaceutical companies in the world. The company is a leader in in vitro diagnostics, molecular and tissue-based cancer diagnostics, and companion diagnostics. Roche's strategy strongly integrates its pharmaceutical and diagnostic divisions to enhance patient care throughout prevention, diagnosis, treatment, and monitoring.

2. Illumina

Illumina, founded in 1998 and based in San Diego, California, is a global leader in DNA sequencing and array-based genomics technologies. Illumina's platforms, such as NovaSeq and MiSeq, are in use in research, clinical genomics, oncology, reproductive health, and infectious disease diagnostics. Illumina has been a pioneer for the accessibility and affordability of next-generation sequencing to help drive personalized medicine. The company strives to innovate in genomics and biomarker discovery, even with regulatory hurdles and trade restrictions.

3. Myriad Genetics

Myriad Genetics, established in 1991 and out of Salt Lake City, Utah, is a molecular diagnostics company focused on hereditary cancer testing, pharmacogenomics, and companion diagnostics. The company is best known for its BRCA1/2 tests that assess risk for breast and ovarian cancer, but that isn't all the company does. Myriad now sells prognostic and tumor profiling tests to help inform treatment decisions. The company has been realigning itself to better focus on high-growth markets and reimbursement adjustments.

4. Agilent Technologies

Created in 1999, Agilent Technologies emerged as a business spin-off of Hewlett-Packard. Agilent is headquartered in Santa Clara, California. Agilent manufactures instruments, software, reagents, and provides services to life sciences, diagnostics, and applied markets such as food safety and environmental testing.

5. Thermo Fisher Scientific

Founded in 1956 and headquartered in Waltham, Massachusetts, Thermo Fisher Scientific is currently one of the largest suppliers of scientific instrumentation, reagents, consumables, and laboratory services. Thermo Fisher Scientific supplies instrumentation, reagents, and consumables to the research, diagnostics, drug development, and clinical testing markets. Thermo Fisher Scientific continues to investigate opportunities for growth through acquisitions that would enhance their current product portfolio while substantively investing in manufacturing, R&D, and existing operations in emerging markets!

6. QIAGEN

QIAGEN is a molecular technology company with a focus on sample-to-insight solutions, which was founded in 1984 and is headquartered in Venlo, Netherlands, with a major office in Hilden, Germany. QIAGEN offers a wide portfolio of products that include sample preparation, nucleic acid extraction, PCR assays, and bioinformatics tools. QIAGEN has a strong background in infectious disease and oncology testing, servicing both human healthcare diagnostics and life sciences.

7. bioMérieux

bioMérieux, founded in 1963 and headquartered in Marcy-l’Étoile, France, is a leader in in vitro diagnostics. bioMérieux serves the diagnostics market with a specialization in infectious diseases and public health applications. bioMérieux manufactures instruments to provide the in vitro diagnostics workflow with reagents and software for clinical testing and industrial testing, including for food and environmental safety.

8. Quest Diagnostics

Founded in 1967 and based in Secaucus, NJ, Quest Diagnostics is one of the largest testing and laboratory services companies in the United States. The company operates an extensive network of labs and patient service centers to deliver clinical chemistry, molecular diagnostics, and biomarker testing across a broad array of diseases. Quest's strengths are derived from its scale and accessibility, providing the ability to be a trusted partner for hospitals, clinics, and insurers.

9. Pfizer

Pfizer is a pharmaceutical behemoth officially incorporated in 1849 in New York City that is known for developing novel medicines and vaccinations. While it primarily sells pharmaceuticals, the organization is also very involved in biomarker-driven drug development and frequently collaborates with diagnostics companies to develop companion diagnostics.

10. Abbott Laboratories

Abbott Laboratories was established in 1888 and is headquartered in Abbott Park, Illinois. Abbott Laboratories is a diversified healthcare company with extensive operations in the fields of diagnostics, medical devices, and nutrition. Abbott's diagnostics business develops biomarker tests related to infectious diseases, chronic illnesses, and cardiovascular health along with point-of-care and laboratory systems.

Other Leading Global Biomarkers Companies

• PerkinElmer
• Siemens Healthineers
• Becton, Dickinson and Company (BD)
• GE Healthcare
• Bruker Corporation
• Bio-Techne Corporation
• Charles River Laboratories
• Fluidigm Corporation
• Novartis AG
• Merck KGaA
• Danaher Corporation
• Gilead Sciences

Conclusion

In conclusion, the biomarkers market is expected to continue its consistent growth as healthcare systems globally adopt a growing focus on early detection of diseases, precision medicine, and better therapeutic results. The synergy between technology and the rising burden of disease and increased funding for research is catalysing the broader utilization of biomarkers in all aspects of diagnostics, drug development and clinical studies. The growth in applications of biomarkers in personalized medicine, along with supportive regulatory priorities suggests the market will have an important role to play in changing the way we care for patients and provide healthcare provision in the future.